# Effect of Prophylactic Tranexamic Acid on Peripartum Changes in Haemoglobin Concentration After Vaginal Delivery

**Authors:** Ezukwa E. Omoronyia, Moses I. Ekuma, Edu Eyong, Sylvester E. Abeshi, Ubong B. Akpan

PMC · DOI: 10.18295/squmj.10.2024.055 · Sultan Qaboos University Medical Journal · 2025-05-16

## TL;DR

This study shows that adding tranexamic acid to oxytocin after vaginal delivery helps prevent a drop in hemoglobin levels, which is important for preventing postpartum anemia.

## Contribution

The study demonstrates that prophylactic tranexamic acid, when combined with oxytocin, effectively reduces postpartum hemoglobin decline in low-risk deliveries.

## Key findings

- Tranexamic acid plus oxytocin significantly increased postpartum hemoglobin concentration compared to oxytocin alone.
- No major maternal side effects were observed in either group.
- The combination is recommended for active management of the third stage of labor.

## Abstract

This study aimed to evaluate the effect of prophylactic intravenous tranexamic acid on postpartum haemoglobin (Hb) concentration values compared to a control group.

This randomised controlled study took place from May to July 2023 and included parturients with no apparent risk for postpartum haemorrhage from the University of Calabar Teaching Hospital in Calabar, Nigeria. Participants were divided equally into 2 groups. Group A (intervention group) received 10 IU of intramuscular oxytocin along with 1,000 mg of intravenous tranexamic acid within 1 minute of vaginal delivery, while Group B (control group) received 10 IU of intramuscular oxytocin with 10 mL of sterile water. The primary outcome measure was the difference in admission and postpartum Hb concentration.

A total of 80 parturients were included in this study; 40 were allocated to each study arm. The demographic characteristics and admission parameters of the 2 groups showed no significant statistical difference (P >0.05). The mean postpartum Hb concentration was significantly higher in Group A compared to Group B (10.28 ± 0.59 mL versus 9.44 ± 0.62 mL; P <0.001). No major maternal side effects were reported in either group.

Compared to the placebo plus oxytocin, tranexamic acid plus oxytocin exhibited effectiveness in reducing postpartum Hb drop after vaginal delivery. Therefore, the use of tranexamic acid plus oxytocin is recommended as part of the active management of the third stage of labour.

## Linked entities

- **Chemicals:** tranexamic acid (PubChem CID 5526), oxytocin (PubChem CID 439302)

## Full-text entities

- **Diseases:** postpartum haemorrhage (MESH:D006473)
- **Chemicals:** oxytocin (MESH:D010121), Tranexamic Acid (MESH:D014148)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12244327/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12244327/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12244327/full.md

---
Source: https://tomesphere.com/paper/PMC12244327